These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6310437

  • 1. Cushing's disease in childhood: benign intracranial hypertension after trans-sphenoidal adenomectomy. Case report.
    Weissman MN, Page LK, Bejar RL.
    Neurosurgery; 1983 Aug; 13(2):195-8. PubMed ID: 6310437
    [Abstract] [Full Text] [Related]

  • 2. Development of pseudotumor cerebri after the removal of an adrenocorticotropic hormone-secreting pituitary adenoma: case report.
    Martin NA, Linfoot J, Wilson CB.
    Neurosurgery; 1981 Jun; 8(6):699-702. PubMed ID: 6269017
    [Abstract] [Full Text] [Related]

  • 3. Recurrent Cushing's disease: successful treatment by pituitary irradiation or trans-sphenoidal hypophysectomy in two cases.
    Caplan RH, Annis BL.
    Neurosurgery; 1980 Aug; 7(2):160-5. PubMed ID: 6252506
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
    Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
    [Abstract] [Full Text] [Related]

  • 5. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J, Knappe UJ, Lüdecke DK.
    Zentralbl Neurochir; 2003 Jun; 64(1):6-11. PubMed ID: 12582940
    [Abstract] [Full Text] [Related]

  • 6. Benign intracranial hypertension after pituitary surgery for Cushing's disease.
    Parfitt VJ, Dearlove JC, Savage D, Griffith HB, Hartog M.
    Postgrad Med J; 1994 Feb; 70(820):115-7. PubMed ID: 8170882
    [Abstract] [Full Text] [Related]

  • 7. Cushing's disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma.
    Puchner MJ, Lüdecke DK, Valdueza JM, Saeger W, Willig RP, Stalla GK, Odink RJ.
    Neurosurgery; 1993 Nov; 33(5):920-4; discussion 924-5. PubMed ID: 8264895
    [Abstract] [Full Text] [Related]

  • 8. The neurosurgical management of Cushing's disease.
    Reitmeyer M, Vance ML, Laws ER.
    Mol Cell Endocrinol; 2002 Nov 29; 197(1-2):73-9. PubMed ID: 12431799
    [Abstract] [Full Text] [Related]

  • 9. Pituitary macroadenoma and Cushing's disease in pediatric patients: patient report and review of the literature.
    Damiani D, Aguiar CH, Crivellaro CE, Galvão JA, Dichtchekenian V, Setian N.
    J Pediatr Endocrinol Metab; 1998 Nov 29; 11(5):665-9. PubMed ID: 9829219
    [Abstract] [Full Text] [Related]

  • 10. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
    Kuwayama A, Kageyama N, Nakane T, Watanabe M, Kanie N.
    J Clin Endocrinol Metab; 1981 Jul 29; 53(1):165-73. PubMed ID: 6263935
    [Abstract] [Full Text] [Related]

  • 11. [Cushing's disease in childhood: apropos of a case cured after trans-sphenoidal adenomectomy].
    Barrios Castellanos R, Argente Oliver J, Alonso Blanco M, Yturriaga Matarranz R.
    An Esp Pediatr; 1984 Mar 15; 20(4):387-94. PubMed ID: 6732065
    [Abstract] [Full Text] [Related]

  • 12. Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment.
    Tomita A, Suzuki S, Hara I, Oiso Y, Mizuno S, Yogo H, Kuwayama A, Kageyama N.
    Endocrinol Jpn; 1981 Apr 15; 28(2):197-205. PubMed ID: 6273138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A.
    J Clin Endocrinol Metab; 1998 May 15; 83(5):1619-23. PubMed ID: 9589666
    [Abstract] [Full Text] [Related]

  • 16. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate].
    Herrmann BL, Mitchell A, Saller B, Stolke D, Forsting M, Frilling A, Mann K.
    Dtsch Med Wochenschr; 2001 Mar 02; 126(9):232-4. PubMed ID: 11256037
    [Abstract] [Full Text] [Related]

  • 17. [Transsphenoidal selective adenomectomy of ACTH adenoma for the treatment of Cushing's disease].
    Ruan WF, Wang WJ, Yin ZY, Ren ZY, Jiang JL, Su CB.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Apr 02; 6(2):92-5. PubMed ID: 6100483
    [No Abstract] [Full Text] [Related]

  • 18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr 02; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 19. [Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy].
    Zgliczyński S.
    Endokrynol Pol; 1982 Apr 02; 33(4-6):285-94. PubMed ID: 7185571
    [No Abstract] [Full Text] [Related]

  • 20. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease.
    Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K, Kageyama N.
    Neurosurgery; 1987 Aug 02; 21(2):218-22. PubMed ID: 2821447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.